Posted Jan. 21, 2014 at 2:36 p.m.

Premium Lock Argos prices $60M IPO at $13 to $15 per share

Published: 2014-01-21 14:36:48
Updated: 2014-01-21 14:36:48

Argos Argos

At the $14 per share midpoint Argos Therapeutics would have a $247 million valuation and the cancer immunotherapy company would raise $60 million to finance late stage clinical trials for its kidney cancer treatment....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Dr. Mike Walden
Tech economy
Frank Vinluan
Life science
Vivek Wadhwa
Commentary
Scroll